LOGIN TO OUR AMALGEROL TRIAL DATABASE
Incorrect access data.
Register
FORGOT YOUR PASSWORD?

Enter your username or email address and we will send you a link to reset your password.

Please check your email
website.reset-password.error
User Read Only User Full Access
Create new trial
de
Open Lightbox
T0331-b

T0331-b

Olive DEMO trial series (B): AMALGEROL boosts yield and vegetative growth in mature (3-year-old) olive trees

# side shoot formation, shoot development, crop establishment

Olive

Spain

AMALGEROL®

Olive DEMO trial series (B): AMALGEROL boosts yield and vegetative growth in mature (3-year-old) olive trees

In 2018, a field trial was conducted in Arahal, Seville (Southern Spain) to assess the performance of AMALGEROL® on mature olive trees aged between 3 to 4 years. The objective was to measure its impact on plant growth, yield, and overall crop health compared to the standard farmer practice.

 

The trial included two applications of AMALGEROL via drip irrigation during the spring.

Over the course of the season, trees treated with AMALGEROL consistently outperformed those under standard management. The number of side shoots per tree increased by nearly 10%, and both the length of side shoots (+14.1%) and terminal shoots (+13.1%) improved substantially. These growth parameters reflect stronger vegetative development and canopy expansion.

 

In addition to enhanced growth, the AMALGEROL treatment delivered a 7.7% increase in total fruit yield (kg/ha) at harvest. While yield and vegetative growth improved, these results suggest a trade-off with smaller, slightly less oil-rich fruits under AMALGEROL treatment. Throughout the trial, no phytotoxic effects were observed, and AMALGEROL-treated trees consistently maintained a higher crop vigour score.

+ 13.1% increase in terminal shoot length
+ 14.1% increase in side shoot length
+ 9.6% increase in number of side shoots
+ 7.7% increase in total fruit yield (kg/ha)
Open Lightbox
T0331-b

T0331-b

Open Lightbox
T0331-b

T0331-b

Open Lightbox
T0331-b

T0331-b

NEWSLETTER

Stay updated with the latest trials and news from AMALGEROL.

Successfully registered for newsletter
Unfortunately something didn't work.

To read the entire article, please log in.